- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Sleep Apnea, Obstructive in South Africa
Total 1062 results
-
Macquarie University, AustraliaCompletedChronic Obstructive Pulmonary Disease (COPD)Australia
-
Alexza Pharmaceuticals, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Endo PharmaceuticalsAlkermes, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
AstraZenecaCompleted
-
University of California, Los AngelesFenzian Ltd.CompletedAsthmaUnited States, South Africa, United Kingdom
-
National Institute on Drug Abuse (NIDA)SunovionCompletedInsomnia | Alcohol ProblemUnited States
-
Woolcock Institute of Medical ResearchUniversity of Sydney; Cooperative Research Centre for Alertness, Safety and...RecruitingChronic Low-back Pain | InsomniaAustralia
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Monash UniversityUniversity of Melbourne; La Trobe University; Institute for Breathing and Sleep... and other collaboratorsRecruitingChronic Obstructive Pulmonary DiseaseAustralia
-
Heidelberg UniversityTerminatedObstructive Lung DiseasesAustralia, Germany
-
Alkermes, Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Black Hills State UniversityCompleted
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease, COPD | Low Peak Inspiratory Flow Rate (PIFR)United States
-
DeyCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
SanofiCompletedInsomnia | Sleep Initiation and Maintenance DisordersCanada, United States, Australia
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
PfizerCompletedChronic Obstructive Pulmonary DiseaseAustralia, Netherlands, Canada, Korea, Republic of, Argentina, Hungary, South Africa, France, Russian Federation, Chile, Czechia, Greece, United Kingdom
-
SanofiCompletedSleep Initiation and Maintenance DisordersUnited States, France, Canada, Brazil, Russian Federation, Netherlands, Switzerland, Turkey, Malaysia, Taiwan, Czech Republic, Finland, Italy, Colombia, South Africa, Greece
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease COPDUnited States, Netherlands, Argentina, South Africa, Chile, Peru
-
Chiesi Farmaceutici S.p.A.Chiesi USA, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States, Czech Republic, Germany, Poland, Romania, South Africa
-
GlaxoSmithKlineCompletedAsthmaGermany, South Africa, Bulgaria
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | COPDUnited States, France, Poland, South Africa, Canada, Germany
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia
-
Xuewen WangCompleted
-
NovartisCompletedChronic Obstructive Pulmonary DiseaseUnited States, Germany
-
Verona Pharma plcIqvia Pty LtdCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseAustralia, United States, New Zealand
-
SunovionCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
GlaxoSmithKlineCompleted
-
Elpen Pharmaceutical Co. Inc.RecruitingCopd | COPD ExacerbationGreece
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Philips RespironicsCompletedSleep Disorder; Breathing-RelatedUnited States
-
Boston Scientific CorporationCompletedAsthmaSpain, Italy, Germany, Netherlands, Australia, Czechia, South Africa, United Kingdom
-
University of South CarolinaLiteboook CompanyCompleted
-
VA Office of Research and DevelopmentRecruitingSuvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic StressSleep Initiation and Maintenance Disorders | Stress Disorders, PosttraumaticUnited States
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustralia, New Zealand, United Kingdom
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Thorne Research Inc.CompletedSleep | Mood | Gastrointestinal Health | General Wellbeing | Physical DiscomfortUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, Russian Federation, Estonia, Netherlands, South Africa, Korea, Republic of, Slovenia, New Zealand, Finland, Latvia, Lithuania, United Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, Romania, Ukraine, Estonia, Russian Federation, South Africa, Sweden, Netherlands, Slovakia
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldRecruitingIleus | Small Bowel Obstruction | Intestinal FailureUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia
-
US Department of Veterans AffairsCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
TakedaCompleted
-
Novartis PharmaceuticalsCompletedCOPDSpain, Germany, Belgium, Poland, South Africa, Australia, Greece, Israel, Sweden, Hong Kong, Thailand, Bulgaria, Singapore, Denmark, Finland, Hungary, Romania, Malaysia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveSouth Africa, United States, Canada, Ukraine, United Kingdom, Denmark, Czechia
-
Lowcountry Infectious DiseasesUnknown